Main > > >DIABETIC RETINOPATHY. *

Ophthalmo.>DIAG.: Artificial
Intelligence (AI). (U>E)
CA Approval Date : 2018. 03.08.
EU Approval Date : 2015. 04.14.
USA Approval Date: 2020. 08.05.
(*) Company; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2020. 08.06.




Ophthalmo.>DIAG.: Artificial
Intelligence (AI).
USA Approval Date: 2018. 04.12.
(*) Company : IDx Inc.
Web-Site :
www.eyediagnosis.net/diabetes
UpDate: 2018. 04.13.




Ophthalmo.>DIAG.: Artificial
Intelligence (AI)+TeleHealth. (U>2).
(*) Company; Patents & Web-Sites Avai-
lable on Request.
UpDate: 2018. 10.14.




Ophthalmo.>TREAT.: RanibizuMAb Inj. (U)
USA (PFS) Approval: 2018. 03.21.
USA Approval : 2017. 04.18.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 07.02.




>DIABETIC RETINOPATHY. *'s products
This section has no products